PATENT CLAIM ANALYSIS

Application Number: 15780462
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "210180"]

Abstract:
Use of a GPR119 agonist in the prevention or treatment of hypoglycemia is disclosed, addition, pharmaceutical compositions and combinations of a GPR1 19 agonist with insulin, insulin analog, insulin secretagogue or or other drug(s) that reduces plasma glucose levels to below 70 mg/dL described herein.

Claim (Index 16):
An article of manufacture that comprises a container holding:\n (a) a pharmaceutical composition comprising a GPR119 agonist and a pharmaceutically acceptable carrier; and (b) printed instructions for treating hypoglycemia in a subject diagnosed as having hypoglycemia by using the pharmaceutical composition.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.2619
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12610639', '12610682', '12610877', '11927535', '11927621']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.762568203117429
- 35 USC 102 Novelty (BERT): 0.5219606306936261
- Combined Prediction Score: 0.7385074458750488
- Mean Citation Score: 282.4480779999999
- Max Citation Score: 288.3848
- Similarity Product: 173.29179982323646

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test